WETH:NASDAQWetouch Technology Inc. Analysis
Data as of 2026-06-22 - not real-time
$1.34
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Wetouch Technology (WETH) is trading at $1.34, well below its 20‑day, 50‑day and 200‑day SMAs of $1.43, $1.60 and $1.66 respectively, signalling a bearish technical backdrop. The RSI of 40.7 suggests momentum is not yet oversold, while the MACD line sits just above its signal, offering a faint bullish hint that has not materialised in price. Volume is on a decreasing trend, and 30‑day volatility spikes at 75 %, compounded by a high beta of ~1.5, underscoring pronounced price swings. Despite these pressures, the stock’s fundamentals are strikingly cheap: a trailing PE of 1.9 versus an industry average of 38, a price‑to‑book of 0.12 on a book value of $11.33 per share, and a DCF‑derived fair value of roughly $20.85, implying deep undervaluation. Cash sits at $120 M against modest debt of $0.37 M, yielding a debt‑to‑equity of 0.26 and supporting strong liquidity. Operating margins hover around 31 % with an 18 % profit margin, and revenue is growing modestly at 6.7 % YoY, indicating a resilient business model. Recent market sentiment turned negative for tech stocks after a stronger‑than‑expected jobs report, which may have added headwinds to WETH’s already fragile price action.
Given the valuation gap and solid balance sheet, the long‑run outlook is positive, but short‑term upside is constrained by technical weakness and elevated risk metrics. The stock’s small market cap (~$16 M) and shrinking daily volume raise liquidity concerns, while its China‑centric exposure introduces medium‑to‑high regulatory and geographic risk. Investors should weigh the upside potential against the high volatility and liquidity constraints when forming a position.
Given the valuation gap and solid balance sheet, the long‑run outlook is positive, but short‑term upside is constrained by technical weakness and elevated risk metrics. The stock’s small market cap (~$16 M) and shrinking daily volume raise liquidity concerns, while its China‑centric exposure introduces medium‑to‑high regulatory and geographic risk. Investors should weigh the upside potential against the high volatility and liquidity constraints when forming a position.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below all major moving averages
- decreasing volume trend
- proximity to near‑term support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- extreme valuation discount relative to peers
- strong cash position and low debt
- persistent high volatility and beta
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value far exceeds current price
- robust operating margins and steady revenue growth
- significant upside potential if market risk subsides
Key Metrics & Analysis
Financial Health
Revenue Growth6.70%
Profit Margin18.34%
P/E Ratio1.9
ROE6.25%
ROA4.93%
Debt/Equity0.26
P/B Ratio0.1
Op. Cash Flow$5.9M
Free Cash Flow$7.3M
Industry P/E38.1
Technical Analysis
TrendBearish
RSI40.7
Support$1.31
Resistance$1.70
MA 20$1.43
MA 50$1.60
MA 200$1.66
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value$20.85
GradeUndervalued
TypeValue
Risk Assessment
Beta1.50
Volatility75.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.